Opus Genetics Inc (IRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 4,302 | 3,867 | 1,112 | 1,711 | 1,691 |
| Gross Profit | 4,302 | 3,867 | 1,112 | 1,711 | 1,691 |
| Operating Expenses | 42,331 | 11,876 | 9,440 | 9,419 | 7,120 |
| Operating Income | -38,029 | -8,009 | -8,328 | -7,708 | -5,429 |
| Other Income | 2,894 | 483 | 563 | 602 | 632 |
| Pre-tax Income | -35,135 | -7,526 | -7,765 | -7,106 | -4,797 |
| Income Tax | N/A | N/A | N/A | N/A | -2 |
| Net Income Continuous | -35,135 | -7,526 | -7,765 | -7,106 | -4,795 |
| Net Income | $-35,135 | $-7,526 | $-7,765 | $-7,106 | $-4,795 |
| EPS Basic Total Ops | -1.27 | -0.29 | -0.30 | -0.29 | -0.20 |
| EPS Basic Continuous Ops | -1.28 | -0.29 | -0.30 | -0.29 | -0.21 |
| EPS Diluted Total Ops | -1.27 | -0.29 | -0.30 | -0.29 | -0.19 |
| EPS Diluted Continuous Ops | -1.28 | -0.29 | -0.30 | -0.29 | -0.20 |
| EPS Diluted Before Non-Recurring Items | -1.27 | -0.29 | -0.30 | N/A | N/A |
| EBITDA(a) | $-38,029 | $-8,009 | $-8,328 | $-7,708 | $-5,426 |